Showing 45,121 - 45,140 results of 45,291 for search '"type 2 diabetes"', query time: 1.69s Refine Results
  1. 45121

    Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice by Zhu Y, Li ZL, Ding A, Yang H, Zhu WP, Cui TX, Zhang HT, Zhang H

    Published 2019-10-01
    “…Yet, whether OM affects DN progression and renal injury in db/db mice, a type 2 diabetic murine model, has not been established.Methods: Wild-type (n = 15) and db/db mice (n = 15) were treated with control saline or OM via oral gavage. …”
    Get full text
    Article
  2. 45122

    Hernia incisional eviscerada: A propósito de un caso by Alejandro Barrabí Díaz, Joaquín Márquez Hernández, Evelio Salvador Reyes Balseiro, Bárbaro Agustín Armas Pérez

    Published 2017-11-01
    “…Case report: A 78 years old, aged woman, type II diabetic, with vitiligo, controlled hypertension , carrier of incisional hernia too, voluminous, recurrent, which suffered spontaneous rupture of wall and skin, with evisceration. …”
    Get full text
    Article
  3. 45123
  4. 45124
  5. 45125

    UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. by Turner, R, Holman, R, Matthews, D, Oakes, S, Bassett, P, Stratton, I, Cull, C, Manley, S, Frighi, V

    Published 1991
    “…Newly presenting Type 2 diabetic patients aged 25-65 years inclusive, median age 53 years, median body mass index 28 kg/m2 and median fasting plasma glucose 11.3 mmol/l, were recruited and treated initially by diet. …”
    Journal article
  6. 45126

    Health impacts of takeaway management zones around schools in six different local authorities across England: a public health modelling study using PRIMEtime by Rogers, NT, Amies-Cull, B, Adams, J, Chang, M, Cummins, S, Derbyshire, D, Hassan, S, Keeble, M, Liu, B, Medina-Lara, A, Savory, B, Rahilly, J, Smith, R, Thompson, C, White, M, Mytton, O, Burgoine, T

    Published 2024
    “…Model estimates showed reductions in incidence of disease, including type II diabetes (e.g. 964 (95% UI: 1565, 870) fewer cases/100,000 population for males in Manchester)), cardiovascular diseases, asthma, certain cancers, and low back pain. …”
    Journal article
  7. 45127

    Investigation of carbon footprint emission for highway bridge construction in Malaysia by Jawad Musafer, Karar Nadhum

    Published 2021
    “…However, in Iraq, the prevalence of type II diabetes mellitus (T2DM) is particularly due to many different factors, one of which is genetics. …”
    Get full text
    Thesis
  8. 45128

    SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice by Xialin Zhu, Yun Chen, Xu Xu, Xiaoju Xu, Yin Lu, Xi Huang, Jinpei Zhou, Lihong Hu, Jiaying Wang, Xu Shen

    Published 2020-11-01
    “…Methods: STZ-induced type 1 diabetic mice with DPN (STZ mice) were defined at 12 weeks of age (4 weeks after STZ injection) through behavioral tests, and db/db (BKS Cg-m+/+Leprdb/J) type 2 diabetic mice with DPN (db/db mice) were at 18 weeks of age. …”
    Get full text
    Article
  9. 45129

    Obesidade e fatores de risco para o desenvolvimento de doenças crônicas não transmissíveis entre usuários de unidade de alimentação e nutrição Obesity and risk factors for the deve... by Aline Brandão Mariath, Luciane Peter Grillo, Raquel Oliveira da Silva, Patrícia Schmitz, Isabel Cristina de Campos, Janete Rosa Pretto Medina, Rejane Magda Kruger

    Published 2007-04-01
    “…High systolic blood pressure (SBP) and diastolic blood pressure (DBP) were present in 18% and 11% of the employees, respectively, with a significant association between genders after adjusting for age. Type II diabetes mellitus was diagnosed in 2% of the sample and altered glucose levels in 4%. …”
    Get full text
    Article
  10. 45130

    Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation by Alex Ali Sayour, Sevil Korkmaz-Icöz, Sivakkanan Loganathan, Mihály Ruppert, Viktor Nabil Sayour, Attila Oláh, Kálmán Benke, Maik Brune, Rita Benkő, Eszter Mária Horváth, Matthias Karck, Béla Merkely, Tamás Radovits, Gábor Szabó

    Published 2019-04-01
    “…Abstract Background The sodium–glucose cotransporter-2 (SGLT2) inhibitor canagliflozin has been shown to reduce major cardiovascular events in type 2 diabetic patients, with a pronounced decrease in hospitalization for heart failure (HF) especially in those with HF at baseline. …”
    Get full text
    Article
  11. 45131

    Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma by Muhammad Zubair Afzal, Rima R. Mercado, Keisuke Shirai

    Published 2018-07-01
    “…Abstract Background Metformin is one of the biguanides commonly used in patients with type II Diabetes Mellitus. Apart from its hypoglycemic properties, metformin also inhibits the cell cycle by restricting protein synthesis and cell proliferation via regulating the LKB1/AMPL pathway. …”
    Get full text
    Article
  12. 45132

    Natural history and clinical significance of aortic focal intimal flaps by Austin Maas, Pieter A. J. van Bakel, Pieter A. J. van Bakel, Yunus Ahmed, Yunus Ahmed, Himanshu J. Patel, Nicholas S. Burris

    Published 2022-10-01
    “…Common co-morbidities included: hypertension (78%), hyperlipidemia (68%), smoking (60%), coronary artery disease (41%), aortic aneurysm (34%), type II diabetes mellitus (27%) and prior cardiovascular surgery (25%). …”
    Get full text
    Article
  13. 45133
  14. 45134

    The analysis for time of referral to a medical center among patients with diabetic foot infection by Cheng-Wei Lin, Hui-Mei Yang, Shih-Yuan Hung, I-Wen Chen, Yu-Yao Huang

    Published 2021-01-01
    “…Methods This retrospective research studied consecutive type 2 diabetic patients with DFI treated at the major diabetic foot center in Taiwan from 2014 to 2017. …”
    Get full text
    Article
  15. 45135

    Supplementation with a New Standardized Extract of Green and Black Tea Exerts Antiadipogenic Effects and Prevents Insulin Resistance in Mice with Metabolic Syndrome by Mario De la Fuente-Muñoz, María De la Fuente-Fernández, Marta Román-Carmena, Sara Amor, María C. Iglesias-de la Cruz, Guillermo García-Laínez, Silvia Llopis, Patricia Martorell, David Verdú, Eva Serna, Ángel L. García-Villalón, Sonia I. Guilera, Antonio M. Inarejos-García, Miriam Granado

    Published 2023-05-01
    “…Insulin resistance is one of the main characteristics of metabolic syndrome (MetS) and the main cause of the development of type II diabetes. The high prevalence of this syndrome in recent decades has made it necessary to search for preventive and therapeutic agents, ideally of natural origin, with fewer side effects than conventional pharmacological treatments. …”
    Get full text
    Article
  16. 45136

    “Ancestral recipes”: a mixed-methods analysis of MyPlate-based recipe dissemination for Latinos in rural communities by Ann Marie Cheney, William J. McCarthy, María Pozar, Christina Reaves, Gabriela Ortiz, Diana Lopez, Perla A. Saldivar, Lillian Gelberg

    Published 2023-02-01
    “…Abstract Background The Latinx population experiences some of the highest rates of chronic disease, including obesity and type II diabetes. Such conditions may be especially burdensome in rural Latinx communities that often face barriers to accessing disease prevention resources and public health programs. …”
    Get full text
    Article
  17. 45137
  18. 45138

    Effect of a Fixed Combination of Curcumin, Artemisia, Bromelain, and Black Pepper Oral Administration on Optical Coherence Tomography Angiography Indices in Patients with Diabetic... by Flavia Chiosi, Michele Rinaldi, Giuseppe Campagna, Gianluigi Manzi, Vincenzo De Angelis, Francesco Calabrò, Luca D’Andrea, Fausto Tranfa, Ciro Costagliola

    Published 2022-04-01
    “…Conclusions: A fixed combination of Curcumin, Artemisia, Bromelain, and Black pepper oral administration may have a positive impact on central retinal thickness, visual acuity, and VD of the DCP in compensated type 2 diabetic patients with mild DME.…”
    Get full text
    Article
  19. 45139

    Essentiality of the Maltase AmlE in Maltose Utilization and Its Transcriptional Regulation by the Repressor AmlR in the Acarbose-Producing Bacterium Actinoplanes sp. SE50/110 by Lena Schaffert, Susanne Schneiker-Bekel, Susanne Schneiker-Bekel, Saskia Dymek, Julian Droste, Marcus Persicke, Tobias Busche, David Brandt, Alfred Pühler, Jörn Kalinowski

    Published 2019-10-01
    “…SE50/110 is the wild type of industrial production strains of the fine-chemical acarbose (acarviosyl-maltose), which is used as α-glucosidase inhibitor in the treatment of type II diabetes. Although maltose is an important building block of acarbose, the maltose/maltodextrin metabolism has not been studied in Actinoplanes sp. …”
    Get full text
    Article
  20. 45140

    Epigenetic and transcriptomic alterations in the ClC-3-deficient mice consuming a normal diet by Zhenghui Jing, Zhenghui Jing, Haifeng Zhang, Haifeng Zhang, Yunjie Wen, Shiyu Cui, Shiyu Cui, Yuhua Ren, Yuhua Ren, Rong Liu, Rong Liu, Sirui Duan, Wenbao Zhao, Lihong Fan

    Published 2023-05-01
    “…A total of 92 genes were intersected between DEGs and DMRs-targeted genes, of which Nos3, Pik3r1, Socs1, and Acly were gathered in type II diabetes mellitus, insulin resistance, and metabolic pathways. …”
    Get full text
    Article